Similar articles

• Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.

  Lonn E, Shaikholeslami R, Yi Q, Bosch J, Sullivan B, Tanser P, Magi A, Yusuf S. Lonn E, et al. J Am Coll Cardiol. 2004 Jun 16;43(12):2200-6. doi: 10.1016/j.jacc.2003.10.073. J Am Coll Cardiol. 2004. PMID: 15193680 Clinical Trial.
• [Symposium "Emerging Approaches to Cardiovascular Diseases: Detailed results and implications of the HOPE Study". Atlanta, 10. November 1999].

  Bischoff A. Bischoff A. Internist (Berl). 2000 Jan;41(1):A24-7. Internist (Berl). 2000. PMID: 10712083 Clinical Trial. German. No abstract available.
• Effect of changes in blood pressure and left ventricular mass induced by antihypertensive treatment on ventricular arrhythmias in essential hypertension.

  Muiesan ML, Zulli R, Rizzoni D, Calebich S, Malerba M, Porteri E, Agabiti-Rosei E. Muiesan ML, et al. J Hypertens Suppl. 1993 Dec;11(5):S104-5. J Hypertens Suppl. 1993. PMID: 8158296 Clinical Trial. No abstract available.
• Hypertensive heart disease.

  Diamond JA, Phillips RA. Diamond JA, et al. Hypertens Res. 2005 Mar;28(3):191-202. doi: 10.1291/hypres.28.191. Hypertens Res. 2005. PMID: 16097361 Review.
• Correlations of left ventricular hypertrophy with cardiovascular mortality.

  Sharpe N. Sharpe N. Int J Clin Pract Suppl. 2000 May;(110):16-22. Int J Clin Pract Suppl. 2000. PMID: 10912303 Review. No abstract available.